Logo image of NVST

ENVISTA HOLDINGS CORP (NVST) Stock Fundamental Analysis

USA - NYSE:NVST - US29415F1049 - Common Stock

21.15 USD
+0.14 (+0.67%)
Last: 9/15/2025, 10:20:51 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NVST. NVST was compared to 191 industry peers in the Health Care Equipment & Supplies industry. NVST has only an average score on both its financial health and profitability. NVST is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

NVST had positive earnings in the past year.
In the past year NVST had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NVST reported negative net income in multiple years.
Each year in the past 5 years NVST had a positive operating cash flow.
NVST Yearly Net Income VS EBIT VS OCF VS FCFNVST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

NVST has a better Return On Assets (0.95%) than 73.30% of its industry peers.
NVST's Return On Equity of 1.71% is fine compared to the rest of the industry. NVST outperforms 74.35% of its industry peers.
NVST has a Return On Invested Capital of 2.95%. This is in the better half of the industry: NVST outperforms 72.25% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NVST is below the industry average of 8.46%.
Industry RankSector Rank
ROA 0.95%
ROE 1.71%
ROIC 2.95%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
NVST Yearly ROA, ROE, ROICNVST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Profit Margin of NVST (2.11%) is better than 74.35% of its industry peers.
NVST's Operating Margin of 7.13% is fine compared to the rest of the industry. NVST outperforms 74.87% of its industry peers.
In the last couple of years the Operating Margin of NVST has declined.
NVST has a Gross Margin (54.79%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of NVST has remained more or less at the same level.
Industry RankSector Rank
OM 7.13%
PM (TTM) 2.11%
GM 54.79%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
NVST Yearly Profit, Operating, Gross MarginsNVST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NVST is destroying value.
The number of shares outstanding for NVST has been increased compared to 1 year ago.
The number of shares outstanding for NVST has been increased compared to 5 years ago.
NVST has a worse debt/assets ratio than last year.
NVST Yearly Shares OutstandingNVST Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NVST Yearly Total Debt VS Total AssetsNVST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.52, we must say that NVST is in the distress zone and has some risk of bankruptcy.
NVST has a Altman-Z score (1.52) which is comparable to the rest of the industry.
NVST has a debt to FCF ratio of 5.60. This is a neutral value as NVST would need 5.60 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.60, NVST is in the better half of the industry, outperforming 79.58% of the companies in the same industry.
A Debt/Equity ratio of 0.46 indicates that NVST is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.46, NVST perfoms like the industry average, outperforming 43.46% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 5.6
Altman-Z 1.52
ROIC/WACC0.42
WACC7.02%
NVST Yearly LT Debt VS Equity VS FCFNVST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

NVST has a Current Ratio of 2.44. This indicates that NVST is financially healthy and has no problem in meeting its short term obligations.
NVST has a Current ratio of 2.44. This is comparable to the rest of the industry: NVST outperforms 49.21% of its industry peers.
A Quick Ratio of 2.08 indicates that NVST has no problem at all paying its short term obligations.
NVST has a Quick ratio of 2.08. This is comparable to the rest of the industry: NVST outperforms 54.45% of its industry peers.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 2.08
NVST Yearly Current Assets VS Current LiabilitesNVST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

4

3. Growth

3.1 Past

NVST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.10%.
The earnings per share for NVST have been decreasing by -28.29% on average. This is quite bad
NVST shows a small growth in Revenue. In the last year, the Revenue has grown by 0.76%.
NVST shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.90% yearly.
EPS 1Y (TTM)-21.1%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%136.36%
Revenue 1Y (TTM)0.76%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%7.74%

3.2 Future

NVST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.46% yearly.
Based on estimates for the next years, NVST will show a small growth in Revenue. The Revenue will grow by 7.74% on average per year.
EPS Next Y55.01%
EPS Next 2Y30.76%
EPS Next 3Y24.3%
EPS Next 5Y33.46%
Revenue Next Year4.74%
Revenue Next 2Y4.03%
Revenue Next 3Y3.67%
Revenue Next 5Y7.74%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NVST Yearly Revenue VS EstimatesNVST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
NVST Yearly EPS VS EstimatesNVST Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.59, NVST is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of NVST indicates a somewhat cheap valuation: NVST is cheaper than 77.49% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, NVST is valued at the same level.
A Price/Forward Earnings ratio of 16.95 indicates a correct valuation of NVST.
Based on the Price/Forward Earnings ratio, NVST is valued cheaper than 81.15% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. NVST is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.59
Fwd PE 16.95
NVST Price Earnings VS Forward Price EarningsNVST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

NVST's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. NVST is cheaper than 84.29% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NVST indicates a rather cheap valuation: NVST is cheaper than 94.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.63
EV/EBITDA 12.9
NVST Per share dataNVST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NVST's earnings are expected to grow with 24.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.45
PEG (5Y)N/A
EPS Next 2Y30.76%
EPS Next 3Y24.3%

More info and screens

0

5. Dividend

5.1 Amount

NVST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVISTA HOLDINGS CORP

NYSE:NVST (9/15/2025, 10:20:51 AM)

21.15

+0.14 (+0.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners117.15%
Inst Owner Change1.34%
Ins Owners0.47%
Ins Owner Change1.64%
Market Cap3.51B
Analysts73
Price Target21.98 (3.92%)
Short Float %6.26%
Short Ratio4.71
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.73%
Min EPS beat(2)8.83%
Max EPS beat(2)14.62%
EPS beat(4)4
Avg EPS beat(4)15.17%
Min EPS beat(4)7.34%
Max EPS beat(4)29.88%
EPS beat(8)4
Avg EPS beat(8)-5.35%
EPS beat(12)6
Avg EPS beat(12)-3.96%
EPS beat(16)10
Avg EPS beat(16)-1.52%
Revenue beat(2)1
Avg Revenue beat(2)2.1%
Min Revenue beat(2)-0.26%
Max Revenue beat(2)4.46%
Revenue beat(4)1
Avg Revenue beat(4)0.78%
Min Revenue beat(4)-0.9%
Max Revenue beat(4)4.46%
Revenue beat(8)1
Avg Revenue beat(8)-1.34%
Revenue beat(12)1
Avg Revenue beat(12)-1.49%
Revenue beat(16)2
Avg Revenue beat(16)-1.88%
PT rev (1m)0.21%
PT rev (3m)12.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.03%
EPS NY rev (1m)10.56%
EPS NY rev (3m)10.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.45%
Revenue NY rev (1m)2.88%
Revenue NY rev (3m)3%
Valuation
Industry RankSector Rank
PE 24.59
Fwd PE 16.95
P/S 1.38
P/FCF 13.63
P/OCF 12.03
P/B 1.12
P/tB 34.02
EV/EBITDA 12.9
EPS(TTM)0.86
EY4.07%
EPS(NY)1.25
Fwd EY5.9%
FCF(TTM)1.55
FCFY7.34%
OCF(TTM)1.76
OCFY8.31%
SpS15.36
BVpS18.89
TBVpS0.62
PEG (NY)0.45
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.95%
ROE 1.71%
ROCE 3.73%
ROIC 2.95%
ROICexc 3.82%
ROICexgc 19.84%
OM 7.13%
PM (TTM) 2.11%
GM 54.79%
FCFM 10.1%
ROA(3y)-6.24%
ROA(5y)-2.61%
ROE(3y)-11.58%
ROE(5y)-5.09%
ROIC(3y)4.17%
ROIC(5y)4.15%
ROICexc(3y)4.97%
ROICexc(5y)5.02%
ROICexgc(3y)81.26%
ROICexgc(5y)N/A
ROCE(3y)5.28%
ROCE(5y)5.25%
ROICexcg growth 3Y-55.07%
ROICexcg growth 5Y-3.56%
ROICexc growth 3Y-21.01%
ROICexc growth 5Y-0.5%
OM growth 3Y-26.92%
OM growth 5Y-10.43%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.9%
GM growth 5Y-1.29%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 5.6
Debt/EBITDA 4.87
Cap/Depr 29.82%
Cap/Sales 1.34%
Interest Coverage 3.77
Cash Conversion 98.48%
Profit Quality 479.37%
Current Ratio 2.44
Quick Ratio 2.08
Altman-Z 1.52
F-Score7
WACC7.02%
ROIC/WACC0.42
Cap/Depr(3y)41.77%
Cap/Depr(5y)41.11%
Cap/Sales(3y)2.19%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.1%
EPS 3Y-28.29%
EPS 5YN/A
EPS Q2Q%136.36%
EPS Next Y55.01%
EPS Next 2Y30.76%
EPS Next 3Y24.3%
EPS Next 5Y33.46%
Revenue 1Y (TTM)0.76%
Revenue growth 3Y0.02%
Revenue growth 5Y1.9%
Sales Q2Q%7.74%
Revenue Next Year4.74%
Revenue Next 2Y4.03%
Revenue Next 3Y3.67%
Revenue Next 5Y7.74%
EBIT growth 1Y-21.02%
EBIT growth 3Y-26.9%
EBIT growth 5Y-8.72%
EBIT Next Year49.83%
EBIT Next 3Y19.75%
EBIT Next 5Y29.05%
FCF growth 1Y61.39%
FCF growth 3Y-0.46%
FCF growth 5Y-1.09%
OCF growth 1Y24.19%
OCF growth 3Y-2.37%
OCF growth 5Y-3.28%